Moreover, gastric tumors with high FSP1 expression exhibit abnormal infiltration patterns of CD8+ T cells and macrophages, indicating that FSP1 may influence treatment efficacy by reshaping the tumor immune microenvironment [65]. The gene discussed is AIFM2; the disease is neoplasm.